Morsy assumed his role in 2011, after Egyptian equity firm Compass Capital’s acquisition of Rameda. Established in 1986, Rameda now operates three manufacturing facilities in Cairo, producing generic pharmaceuticals, nutraceuticals, dietary supplements, and veterinary products. In July 2025, the company announced it would be acquiring two products for depressive and generalized anxiety disorders, and neuropathic pain. Morsy was previously country manager of Pfizer Egypt in 2007.